Cargando…
Tubulointerstitial disease in diabetic nephropathy
Diabetes mellitus is the major cause of end stage renal disease (ESRD). We cannot predict which patient will be affected. ESRD patients suffer an extremely high mortality rate, due to a very high incidence of cardiovascular disease. Several randomized, prospective studies have been conducted to quan...
Autores principales: | Tonolo, Giancarlo, Cherchi, Sara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3968088/ https://www.ncbi.nlm.nih.gov/pubmed/24711709 http://dx.doi.org/10.2147/IJNRD.S37883 |
Ejemplares similares
-
Tubulointerstitial Biomarkers for Diabetic Nephropathy
por: Satirapoj, Bancha
Publicado: (2018) -
Cell biology of diabetic nephropathy: Roles of endothelial cells, tubulointerstitial cells and podocytes
por: Maezawa, Yoshiro, et al.
Publicado: (2015) -
Enhanced myostatin expression and signalling promote tubulointerstitial inflammation in diabetic nephropathy
por: Verzola, Daniela, et al.
Publicado: (2020) -
Targeting tubulointerstitial remodeling in proteinuric nephropathy in rats
por: Yazdani, Saleh, et al.
Publicado: (2015) -
Research: Complications Impact of tubulointerstitial lesions on anaemia in patients with biopsy-proven diabetic nephropathy
por: Mise, K, et al.
Publicado: (2015)